A share price of Leap Therapeutics Inc [LPTX] is currently trading at $3.24, up 4.01%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The LPTX shares have gain 27.56% over the last week, with a monthly amount glided 41.48%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Leap Therapeutics Inc [NASDAQ: LPTX] stock has seen the most recent analyst activity on October 04, 2021, when Mizuho initiated its Buy rating and assigned the stock a price target of $6. On June 29, 2020, Piper Sandler initiated with a Overweight rating and assigned a price target of $6 on the stock. Robert W. Baird started tracking the stock assigning a Outperform rating and suggested a price target of $6 on February 11, 2020. Raymond James downgraded its rating to a Mkt Perform. In a note dated March 07, 2017, Ladenburg Thalmann initiated an Buy rating and provided a target price of $18 on this stock.
Leap Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $1.24 and $10.20. Leap Therapeutics Inc [NASDAQ: LPTX] shares were valued at $3.24 at the most recent close of the market.
Analyzing the LPTX fundamentals
Gross Profit Margin for this corporation currently stands at 0.33% with Operating Profit Margin at -137.29%, Pretax Profit Margin comes in at -128.41%, and Net Profit Margin reading is -127.05%. To continue investigating profitability, this company’s Return on Assets is posted at -1.11, Equity is -1.32 and Total Capital is -1.45. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.04 points at the first support level, and at 2.84 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.47, and for the 2nd resistance point, it is at 3.70.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Leap Therapeutics Inc [NASDAQ:LPTX] is 5.64. In addition, the Quick Ratio stands at 5.64 and the Cash Ratio stands at 5.57.
